Effect of Bushenqiangjin capsule on patients with total knee replacement

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034337

Enrollment

Unknown

Registered

2020-07-02

Start date

2020-07-01

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

terminal knee osteoarthritis

Interventions

experimental group:Bushenqiangjin capsule

control group:Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of knee osteoarthritis; 2. The syndrome type is deficiency of liver and kidney and stagnation of muscles and veins; 3. Sign the informed consent; 4. Perform TKA operation

Exclusion criteria

Exclusion criteria: 1. Non-primary disease; 2. Pregnant or lactating patients; 3. With important system dysfunction, serious chronic cardiovascular and cerebrovascular diseases; 4. Skin breakage, festering, local infection, etc..

Design outcomes

Primary

Measure	Time frame
D-dimer;C-reactive protein;ESR;HSS;VAS;PISQ;isokinetic dynamometer;Musculoskeletal ultrasound;calf/thigh circumference;	—

Countries

China

Contacts

Public ContactXu Xuemeng

Guangdong Second Traditional Chinese Medicine Hospital

xuxuemeng@163.com+86 13602769950

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026